2Seventy Bio

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$8,967
$12,435
$10,684
$12,034
Gross Profit
3,838
5,829
4,507
7,075
EBITDA
-18,680
-46,547
-56,851
-33,758
EBIT
-20,356
-48,654
-59,881
-36,520
Net Income
24,879
-52,673
-56,822
-71,638
Net Change In Cash
8,967
12,435
10,684
12,034
Free Cash Flow
-23,203
-42,489
-64,666
-24,256
Cash
111,864
56,792
74,958
90,226
Basic Shares
55,011
52,071
51,383
51,179

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$100,387
$91,496
$54,522
$248,122
Gross Profit
73,184
65,277
52,005
242,726
EBITDA
-206,418
-251,143
16,057
-113,394
EBIT
-216,703
-262,908
-292,213
-126,582
Net Income
-217,570
-254,144
-292,213
-138,170
Net Change In Cash
100,387
91,496
54,522
248,122
Cost of Revenue
-59,208
163,266
Free Cash Flow
-180,723
-259,976
-226,609
-90,054
Cash
74,958
71,032
130,414
-127,603
Basic Shares
49,276
35,637
23,585
23,287

Earnings Calls

Quarter EPS
2024-06-30
$0.45
2024-03-31
-$1.01
2023-12-31
-$1.11
2023-09-30
-$1